Celcuity Inc. (CELC): Operating Cash Flow
-$153.28M
Year ended 2025-12-31
-$191.71M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$153.28M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$83.47M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$53.81M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$36.01M | n/m | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | -$20.31M | n/m | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | -$7.15M | n/m | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | -$6.00M | n/m | 2021-02-16, From 2019-01-01 |
| 2018-12-31 | -$6.08M | n/m | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | -$4.95M | n/m | 2019-03-01, From 2017-01-01 |
| 2016-12-31 | -$2.89M | n/a | 2018-03-15, From 2016-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Celcuity Inc. (CELC) | 2025-12-31 | -$153.28M | n/m |
| CareDx, Inc. (CDNA) | 2025-12-31 | $42.03M | +10.5% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $64.35M | -0.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $24.59M | n/m |
| Personalis, Inc. (PSNL) | 2025-12-31 | -$74.95M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $83.16M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$101.64M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $136.31M | +81.5% |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$184.76M | n/m |
Compare CELC, CDNA, CSTL, BLLN side by side · Screen every company in Services-Medical Laboratories ↗